Hyaluronic Acid 200 mg

Hyaluronic Acid 200 mg

Vitamatic4.7 (2,561 ratings)
Format:Capsule Quantity: 120 Capsule(s) · 120 servings
Goals
$16.99 $0.14 per serving

Product analysis

75 out of 100

Hyaluronic Acid 200 mg may help improve skin hydration and some visible wrinkle measures. Evidence for joint comfort is more limited and does not establish the effects of joint injections.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

Hyaluronic acid is identified as sodium hyaluronate, but its form quality cannot be compared confidently. The available information does not establish that a particular molecular size offers greater benefit.

Ingredient Transparency100

Amounts and forms are clearly listed for both entries, making the serving easy to compare. There is no mixed-form breakdown needed for the listed ingredients.

Value For Money88

Hyaluronic acid compares favorably with the cost of a serving. That affordability does not establish a greater benefit from a larger amount.

Customer Satisfaction86

Customer ratings are positive. The size of the review pool helps put that satisfaction in context, without proving effectiveness or safety.

Product Focus83

The clearest potential benefit is improved skin hydration, with some support for selected wrinkle measures. Joint-comfort evidence is more limited, and visible skin changes do not establish slower whole-body aging.

Format
Capsule
Container
120 Capsule(s)
Per serving
$0.14
Customer rating
4.7 · 2,561 ratings
Report analysis

Goals

Skin Health
Impact
Highest effect
A+ Ingredient FitC PathwaysA+ EvidenceA+ Formulation Logic
Hyaluronic Acid · 200 mg

Oral hyaluronic acid may improve hydration and some wrinkle measures, with trials including adults with dry skin. The 200 mg serving receives full amount recognition, although a larger amount does not establish a larger benefit than the studied exposures. These findings concern swallowed hyaluronan rather than topical moisturizers, and no molecular-weight superiority is established.

How this product is rated for Skin Health

Ingredient fit96

The formula’s recognized ingredients and disclosed quantities determine its skin focus and amount findings.
Goal fit
The recognized ingredients dominate the formula, while its links to other goals limit how specifically it targets skin.
Dose adequacy
The disclosed amounts receive full recognition under the saved amount curves; this does not establish extra benefit beyond nutritional adequacy.

Pathways60

The assigned coverage is concentrated in the mechanisms below and does not establish benefit across every aspect of skin health.
Depth
The strongest assigned contribution concerns dermal hyaluronan and water binding; this reflects the saved findings rather than a confirmed clinical effect.
Breadth
Only one evaluated mechanism reaches the coverage threshold, leaving the other aspects of skin support limited.

Evidence98

The saved evidence findings recognize the ingredients below, while the supplied scientific context limits expectations for routine skin improvement.
Evidence strength
Hyaluronic Acid supplies the leading recognized evidence contribution, although ingredient context limits what skin benefits can be expected.
Studied preparation
The saved calculation recognizes the counted preparations as studied; ingredient-specific context still limits transfer to routine skin improvement.

Formulation logic100

The counted ingredients have no unmet partner requirement or identified configured conflict. Their minimum amount findings are separate from proof of clinical benefit.
Partner coverage
The counted ingredients have no unmet partner requirement in the saved findings; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict was identified; this finding does not assess overall safety or personal suitability.
Effective doses
All counted ingredients clear the saved minimum amount threshold; passing it does not make each amount a proven effective skin dose.
Study evidence
Longevity
Impact
Highest effect
A+ Ingredient FitD+ PathwaysB+ EvidenceA+ Formulation Logic

Hyaluronic acid may improve skin hydration and selected wrinkle measures, based on small trials lasting about 12 weeks. Its 200 mg serving reaches the full comparison range, without establishing a greater benefit than the lower amount studied. These visible skin findings do not establish slower whole-body aging or longer life.

How this product is rated for Longevity

Ingredient fit96

Hyaluronic acid is the sole credited ingredient and reaches the full comparison range.
Goal fit
Hyaluronic acid is the sole credited ingredient and reaches the full comparison range..
Dose adequacy
The credited amount or amounts reach the full comparison range, without proving a larger clinical benefit.

Pathways54

The saved findings emphasize skin-matrix renewal. This reflects the ingredient roles rather than proof of longer life.
Depth
The strongest recorded coverage concerns skin-matrix renewal, rather than demonstrated whole-body aging reversal.
Breadth
One category reaches the saved breadth threshold; smaller contributions do not add broad coverage.

Evidence82

Hyaluronic acid leads the saved evidence finding, with small trials supporting limited hydration and wrinkle outcomes.
Evidence strength
Hyaluronic acid leads the saved evidence finding, with small trials supporting limited hydration and wrinkle outcomes.
Studied preparation
Eligible ingredients receive preparation recognition in the saved findings, without establishing broader anti-aging effects.

Formulation logic100

No missing required partner or configured conflict was identified; all credited ingredients pass the saved minimum-amount threshold.
Partner coverage
The credited ingredients can stand alone or have their required partner; this does not establish an added combination benefit.
Conflicts
No configured conflict was identified from the supplied facts.
Effective doses
All credited ingredients pass the saved minimum-amount threshold; this does not establish clinical anti-aging efficacy.
Study evidence
Joint Health
Impact
High effect
A+ Ingredient FitC PathwaysB EvidenceA+ Formulation Logic
Hyaluronic Acid · 200 mg

Oral hyaluronic acid has limited evidence for knee comfort in osteoarthritis. The relevant study included quadriceps exercise and reported uncertain incremental or subgroup benefits. The 200 mg per serving reaches the full saved amount allowance. Oral supplementation does not establish the effects of injections or restoration of joint fluid.

How this product is rated for Joint Health

Ingredient fit96

Oral hyaluronic acid provides the main ingredient allowance. The counted amount reaches the full comparison range.
Goal fit
Oral hyaluronic acid supplies the main saved ingredient connection; broader product purposes and other actives affect focus.
Dose adequacy
Oral hyaluronic acid reaches the full saved amount comparison, which does not establish clinical effectiveness.

Pathways60

The saved findings center on joint lubrication. Coverage remains limited to that route.
Depth
The strongest saved contribution concerns joint lubrication; this does not demonstrate structural repair or a measured clinical effect.
Breadth
Only joint lubrication reaches the saved breadth criterion; the remaining assessed routes have no qualifying coverage.

Evidence79

Oral hyaluronic acid evidence has uncertain incremental benefit alongside exercise, with limited or subgroup findings.
Evidence strength
Oral hyaluronic acid evidence has uncertain incremental benefit alongside exercise, with limited or subgroup findings.
Studied preparation
The oral ingredient receives the saved preparation allowance; this does not establish equivalence to injected hyaluronic acid.

Formulation logic100

The counted ingredients meet the minimum amount criterion, with no missing required partner or identified configured conflict.
Partner coverage
No required ingredient partner is missing in the saved findings.
Conflicts
No configured ingredient conflict was identified.
Effective doses
The counted ingredients meet the saved minimum amount criterion, which is not proof of clinical benefit.
Study evidence

Ingredients

IngredientAmount per servingScore
Sodium (Sodium Hyaluronate)
11 mg
Hyaluronic Acid (Sodium Hyaluronate)
200 mg 81
Adults 18–50 Sugar Free
Report overview
D+ Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value
The serving supplies 200 mg of hyaluronic acid as sodium hyaluronate. The amount is specified and the whole-product serving costs about $0.14.
How this ingredient is rated

Active Ingredient Quality & Bioavailability53

Sodium hyaluronate is the recorded form; the source and production method are not identified in the saved facts.
Molecular Weight & Form Optimization
Sodium hyaluronate is the recorded salt form of hyaluronic acid.
Source Transparency & Purity Signals
The saved facts do not identify the hyaluronic acid source or production method.

Dose, Safety & Label Transparency100

The serving specifies 200 mg of hyaluronic acid, a substantial amount in this comparison.
Hyaluronic Acid Dosage Potency
The serving provides 200 mg of hyaluronic acid, a substantial amount in this comparison.
Label Precision & Transparency
The hyaluronic acid amount is specified as 200 mg per serving.

Value100

A whole-product serving costs about $0.14 and supplies 200 mg of hyaluronic acid.
Price Per Active Dose
The price is about $0.14 per whole-product serving.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Oral Hyaluronic Acid in Osteoarthritis and Low Back Pain: A Systematic Review.
    de Carvalho JF; Davidson J · Mediterranean journal of rheumatology · 2025
    Systematic review597 participants11 studies pooledJoint Health forHyaluronic Acid
  2. Single intra-articular injection of lightly cross-linked hyaluronic acid reduces knee pain in symptomatic knee osteoarthritis: a multicenter, double-blind, randomized, placebo-controlled trial.
    Petterson SC; Plancher KD · Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2019
    Randomized trial369 participantsJoint Health forHyaluronic Acid
  3. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial.
    Dougados M; Nguyen M; Listrat V; Amor B · Osteoarthritis and cartilage · 1996
    Randomized trial110 participantsJoint Health forHyaluronic Acid
  4. Intra-articular hyaluronic acid compared with corticoid injections for the treatment of rhizarthrosis.
    Fuchs S; Mönikes R; Wohlmeiner A; Heyse T · Osteoarthritis and cartilage · 2006
    Randomized trial56 participantsJoint Health forHyaluronic Acid
  5. Platelet-rich plasma versus hyaluronic acid injection following arthrocentesis for temporomandibular joint disorders under sedation: a comparative clinical study.
    Mahdi MS; Abdulsattar MS · Oral and maxillofacial surgery · 2026
    Randomized trial60 participantsJoint Health forHyaluronic Acid
  6. Effectiveness and Safety of a Cross-linked Hyaluronic Acid Plus Mannitol Filler for the Correction of Nasolabial Folds in Chinese Subjects: A Randomized, Blinded, Controlled Study.
    Wu Y; Ascher B; Yang Z; Bi H; Li L; Zhao H; Wang H; Zhang J; Luo SK · Aesthetic surgery journal · 2026
    Randomized trial390 participantsLongevity forHyaluronic Acid
  7. A hyaluronic acid-based micro-filler improves superficial wrinkles and skin quality: a randomized prospective controlled multicenter study.
    Fanian F; Deutsch JJ; Bousquet MT; Boisnic S; Andre P; Catoni I; Beilin G; Lemmel C; Taieb M; Gomel-Toledano M; Issa H; Garcia P · The Journal of dermatological treatment · 2023
    Randomized trial146 participantsLongevity forHyaluronic Acid
  8. Safety and Effectiveness of a Crosslinked Hyaluronic Acid Filler in Korean Patients for the Correction of Nasolabial Folds: A Randomized, Patient- and Evaluator-Blinded, Paired Study.
    Lee SH; Park E; Won CH · Aesthetic surgery journal · 2026
    Randomized trial100 participantsLongevity forHyaluronic Acid
  9. Safety and Efficacy of Hyaluronic Acid-Based Filler for Neck Wrinkles: A Prospective, Multicenter, Randomized, Parallel-Controlled Non-Inferiority Trial.
    Jiang M; Cheng H; Li Y; Ai H; Li J; Liang Y; Xu W · Clinical, cosmetic and investigational dermatology · 2026
    Randomized trial188 participantsLongevity forHyaluronic Acid
  10. A randomized study showing improved skin quality and aesthetic appearance of dorsal hands after hyaluronic acid gel treatment in a Chinese population.
    Wu Y; Tian Y; Xu J; Zhong S; Wang R; Wu W · Journal of cosmetic dermatology · 2021
    Randomized trial100 participantsLongevity forHyaluronic Acid
  11. Efficacy and Safety of Sodium Hyaluronate Gel for Facial Skin Rejuvenation.
    Liao Z; Hong W; Wang S; Hou Y; Lu S; Chen R; Zhang Y; Chen J; Liu Y; Luo S · Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2026
    Randomized trial420 participantsSkin Health forHyaluronic Acid
  12. Oral Hyaluronan Relieves Wrinkles and Improves Dry Skin: A 12-Week Double-Blinded, Placebo-Controlled Study.
    Hsu TF; Su ZR; Hsieh YH; Wang MF; Oe M; Matsuoka R; Masuda Y · Nutrients · 2021
    Randomized trial40 participantsSkin Health forHyaluronic Acid
  13. Safety and efficacy of hyaluronic acid injectable filler in the treatment of nasolabial fold wrinkle: a randomized, double-blind, self-controlled clinical trial.
    Li XZ; Chiang CF; Lin YH; Chen TM; Wang CH; Tzeng YS; Cui HY · The Journal of dermatological treatment · 2023
    Randomized trial95 participantsSkin Health forHyaluronic Acid
  14. A Split-Face Study of the Effects of a Stabilized Hyaluronic Acid-Based Gel of Nonanimal Origin for Facial Skin Rejuvenation Using a Stamp-Type Multineedle Injector: A Randomized Clinical Trial.
    Roh NK; Kim MJ; Lee YW; Choe YB; Ahn KJ · Plastic and reconstructive surgery · 2016
    Randomized trial25 participantsSkin Health forHyaluronic Acid
  15. Long-term Safety and Effectiveness of Cold-Crosslinked Hyaluronic Acid Fillers: Multicenter, Randomized, Controlled, Double-Blind Study.
    Kaminer MS; Avelar RL; Baumann L; Callender V; Dayan SH; Green JB; Grekin SK; Guyon S · Aesthetic surgery journal · 2025
    Randomized trial140 participantsSkin Health forHyaluronic Acid